T. A. Andreeva

528 total citations
28 papers, 200 citations indexed

About

T. A. Andreeva is a scholar working on Hematology, Molecular Biology and Astronomy and Astrophysics. According to data from OpenAlex, T. A. Andreeva has authored 28 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 5 papers in Molecular Biology and 2 papers in Astronomy and Astrophysics. Recurrent topics in T. A. Andreeva's work include Hemophilia Treatment and Research (21 papers), Platelet Disorders and Treatments (10 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). T. A. Andreeva is often cited by papers focused on Hemophilia Treatment and Research (21 papers), Platelet Disorders and Treatments (10 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). T. A. Andreeva collaborates with scholars based in Russia, United States and Poland. T. A. Andreeva's co-authors include Lone Hvitfeldt Poulsen, Paul Giangrande, Steven R. Lentz, Pratima Chowdary, S. Ehrenforth, Frank W.G. Leebeek, László Nemes, Elena Santagostino, Johannes Oldenburg and Hideji Hanabusa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Thrombosis and Haemostasis.

In The Last Decade

T. A. Andreeva

22 papers receiving 193 citations

Peers

T. A. Andreeva
Sylvia Reitter-Pfoertner Austria
Richard M. Stone United States
Ying‐Chieh Chiang Taiwan
M. Fuertes Spain
R Prescott United States
Kazuki Terada Japan
María José Sayas Spain
Valeria Cardinali Italy
Ricardo Delumpa United States
S. Songer Australia
Sylvia Reitter-Pfoertner Austria
T. A. Andreeva
Citations per year, relative to T. A. Andreeva T. A. Andreeva (= 1×) peers Sylvia Reitter-Pfoertner

Countries citing papers authored by T. A. Andreeva

Since Specialization
Citations

This map shows the geographic impact of T. A. Andreeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. A. Andreeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. A. Andreeva more than expected).

Fields of papers citing papers by T. A. Andreeva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. A. Andreeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. A. Andreeva. The network helps show where T. A. Andreeva may publish in the future.

Co-authorship network of co-authors of T. A. Andreeva

This figure shows the co-authorship network connecting the top 25 collaborators of T. A. Andreeva. A scholar is included among the top collaborators of T. A. Andreeva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. A. Andreeva. T. A. Andreeva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Voronin, K. A., et al.. (2023). The use of emicizumab in children with hemophilia A without inhibitors in the real-world clinical setting. Pediatric Hematology/Oncology and Immunopathology. 22(4). 96–101.
2.
Andreeva, T. A., et al.. (2023). On Conformal Factor in the Conformal Killing Equation on the 2-Symmetric Five-Dimensional Indecomposable Lorentzian Manifold. Владикавказский математический журнал. 25(3). 5–14.
3.
4.
Andreeva, T. A., В. В. Лебедев, Margarita Timofeeva, et al.. (2022). RESULTS OF OPEN, PROSPECTIVE, MULTICENTER, NON-COMPARATIVE STUDY OF NONACOG ALPHA PHARMACOKINETICS, EFFICACY AND SAFETY IN CHILDREN AGED 2–12 YEARS WITH SEVERE AND MODERATE HEMOPHILIA В. PEDIATRIA Journal named after G N SPERANSKY. 101(1). 193–201. 1 indexed citations
5.
Ettingshausen, Carmen Escuriola, Pavel Svirin, T. A. Andreeva, et al.. (2022). Immune Tolerance Induction (ITI) with a pdFVIII/VWF Concentrate (octanate) in 100 Patients in the Observational ITI (ObsITI) Study. SHILAP Revista de lepidopterología. 6(2). e124–e134. 3 indexed citations
6.
Voronin, K. A., et al.. (2022). Bleeding rate reduction in children with hemophilia A and inhibitors treated with emicizumab in the real-world clinical setting. Pediatric Hematology/Oncology and Immunopathology. 21(1). 66–71. 4 indexed citations
7.
Andreeva, T. A., et al.. (2021). Clinical case of an infant with severe hemophilia A on emicizumab. Russian Journal of Pediatric Hematology and Oncology. 8(3). 123–126. 2 indexed citations
8.
Andreeva, T. A., et al.. (2020). IMMUNOGENICITY STUDY OF THE RUSSIAN RECOMBINANT ACTIVATED COAGULATION FACTOR VII IN HEMOPHILIA A PATIENTS WITH INHIBITORS. PEDIATRIA Journal named after G N SPERANSKY. 99(2). 206–215.
9.
Andreeva, T. A., et al.. (2019). Comparative analysis of calculation methods in electron spectroscopy. Vestnik of Saint Petersburg University Applied Mathematics Computer Science Control Processes. 15(4). 518–528.
10.
Andreeva, T. A., et al.. (2018). Efficacy and safety of the drug Octofactor in prophylactic treatment in patients with severe haemophilia A. Russian Journal of Pediatric Hematology and Oncology. 5(3). 60–73. 2 indexed citations
11.
Andreeva, T. A., et al.. (2017). The efficacy and safety of the drug Octofactor in prophylactic treatment of adolescents with severe hemophilia A. Russian Journal of Pediatric Hematology and Oncology. 4(1). 61–70. 4 indexed citations
12.
13.
Giangrande, Paul, T. A. Andreeva, Pratima Chowdary, et al.. (2016). Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A. Thrombosis and Haemostasis. 117(2). 252–261. 93 indexed citations
14.
Mahlangu, Johnny, T. A. Andreeva, Donald E. Macfarlane, Christopher Walsh, & Nigel S. Key. (2016). Recombinant B‐domain‐deleted porcine sequence factor VIII (r‐pFVIII) for the treatment of bleeding in patients with congenital haemophilia A and inhibitors. Haemophilia. 23(1). 33–41. 19 indexed citations
15.
16.
Stasyshyn, Oleksandra, T. A. Andreeva, L. Rusen, et al.. (2014). Recombinant factor IX (BAX326) in previously treated paediatric patients with haemophilia B: a prospective clinical trial. Haemophilia. 21(2). 196–203. 7 indexed citations
17.
18.
Andreeva, T. A., et al.. (2010). Otsenka obshchetoksicheskikh svoystv preparata geksasens v eksperimente. Russian Journal of Oncology. 15(3). 19–21. 1 indexed citations
19.
20.
Сурин, В. Л., T. Ivaschenko, А. В. Михайлов, et al.. (1994). Allele frequencies and molecular diagnosis in haemophilia A and B patients from russia and from some Asian Republics of the former U.S.S.R.. Prenatal Diagnosis. 14(7). 513–522. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sylvia Reitter-Pfoertner Breakdown of academic impact, for papers by Richard M. Stone Breakdown of academic impact, for papers by Ying‐Chieh Chiang Breakdown of academic impact, for papers by M. Fuertes Breakdown of academic impact, for papers by R Prescott Breakdown of academic impact, for papers by Kazuki Terada Breakdown of academic impact, for papers by María José Sayas Breakdown of academic impact, for papers by Valeria Cardinali Breakdown of academic impact, for papers by Ricardo Delumpa Breakdown of academic impact, for papers by S. Songer
Rankless by CCL
2026